1. Home
  2. ELA vs GNFT Comparison

ELA vs GNFT Comparison

Compare ELA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELA
  • GNFT
  • Stock Information
  • Founded
  • ELA 1965
  • GNFT 1999
  • Country
  • ELA United States
  • GNFT France
  • Employees
  • ELA N/A
  • GNFT N/A
  • Industry
  • ELA Consumer Specialties
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ELA Consumer Discretionary
  • GNFT Health Care
  • Exchange
  • ELA Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • ELA 156.2M
  • GNFT 186.3M
  • IPO Year
  • ELA N/A
  • GNFT 2019
  • Fundamental
  • Price
  • ELA $6.18
  • GNFT $3.83
  • Analyst Decision
  • ELA Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • ELA 1
  • GNFT 1
  • Target Price
  • ELA $9.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • ELA 65.6K
  • GNFT 4.0K
  • Earning Date
  • ELA 08-06-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • ELA N/A
  • GNFT N/A
  • EPS Growth
  • ELA 15.15
  • GNFT N/A
  • EPS
  • ELA 0.28
  • GNFT 0.03
  • Revenue
  • ELA $188,774,278.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • ELA $7.61
  • GNFT $15.98
  • Revenue Next Year
  • ELA $6.27
  • GNFT N/A
  • P/E Ratio
  • ELA $21.59
  • GNFT $120.71
  • Revenue Growth
  • ELA 14.19
  • GNFT 105.01
  • 52 Week Low
  • ELA $4.20
  • GNFT $2.55
  • 52 Week High
  • ELA $7.88
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • ELA 50.27
  • GNFT 41.57
  • Support Level
  • ELA $5.97
  • GNFT $3.44
  • Resistance Level
  • ELA $6.35
  • GNFT $3.81
  • Average True Range (ATR)
  • ELA 0.25
  • GNFT 0.17
  • MACD
  • ELA 0.04
  • GNFT -0.01
  • Stochastic Oscillator
  • ELA 53.73
  • GNFT 38.18

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: